Ainos, Inc. (AIMD)
$
3.62
+0.02 (0.55%)
Key metrics
Financial statements
Free cash flow per share
-1.2012
Market cap
16.8 Million
Price to sales ratio
151.8555
Debt to equity
0.9613
Current ratio
2.8766
Income quality
0.3125
Average inventory
150.9 Thousand
ROE
-1.0825
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Ainos, Inc. is a healthcare company that specializes in the development of medical technologies aimed at point-of-care testing and innovative treatments for various disease indications. The company has made significant strides in its financial performance, as evidenced by its operating income ratio of -667.72 indicating the company's operational profitability margin. Additionally, the gross profit ratio stands at -1.54 reflecting the efficiency of the company's production and sales operations. Ainos achieved a revenue of $20,729.00 showcasing its focus on niche markets. However, the company also incurred an interest expense of $616,467.00 highlighting its obligations related to debt servicing. The weighted average number of shares outstanding is 9,503,618.00 which underscores the company's shareholder base and their stake in the firm. Ainos offers a range of products, including a COVID-19 antigen rapid test kit, a cloud-based test management platform, and a low-dose oral interferon alpha formulation known as Very Low-Dose Oral Interferon Alpha, among other technologies. Formerly known as Amarillo Biosciences, Inc., the company rebranded to Ainos, Inc. in May 2021 and has its headquarters in San Diego, California. The company's stock presents an attractive option for budget-conscious investors, as it is affordable at $3.76. However, it's important to note that the stock has a low average trading volume of 2,328,387.00 indicating lower market activity, which may affect liquidity. With a market capitalization of $16,836,218.00 Ainos is classified as a small-cap player within the healthcare market. It operates within the Biotechnology industry and plays a crucial role in enhancing the overall market landscape. Furthermore, Ainos belongs to the Healthcare sector, where it continues to drive innovation and growth through its advanced medical technologies. The company's strategic focus on point-of-care testing and treatment positions it effectively in the evolving healthcare landscape, allowing it to contribute meaningfully to patient care and medical advancements.
Is Ainos, Inc. (AIMD) a good investment?
Investing in Ainos, Inc. (AIMD) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bearish outlook. Always conduct your own research before investing.
What is Ainos, Inc. (AIMD)'s stock forecast?
Analysts predict Ainos, Inc. stock to fluctuate between $2 (low) and $5 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Ainos, Inc.'s market capitalization?
As of 2025-10-28, Ainos, Inc.'s market cap is $16,836,218, based on 4,650,889 outstanding shares.
How does Ainos, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Ainos, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Ainos, Inc. (AIMD) stock?
To buy Ainos, Inc. (AIMD) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AIMD. Place an order (Market, Limit, etc.).
What is the best time to invest in Ainos, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Has Ainos, Inc. stock ever split?
Ainos, Inc.'s last stock split was 1:5 on 2025-06-30.
How did Ainos, Inc. perform in the last earnings report?
Revenue: $20,729 | EPS: -$1.56 | Growth: -53.57%.
Where can I find Ainos, Inc.'s investor relations reports?
Visit https://ainos.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Ainos, Inc.?
You can explore historical data from here
What is the all-time high and low for Ainos, Inc. stock?
All-time high: $90 (2022-08-04) | All-time low: $0.40 (2024-11-15).
What are the key trends affecting Ainos, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
accessnewswire.com
Collaboration brings AI Nose to the edge, advancing intelligent sensing and industrial sustainability Partnership taps ~$60 billion edge AI market, expanding global industrial channels and accelerating AI Nose commercialization SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 20, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research ("WTR") has published a report highlighting Ainos' strategic partnership with NEXCOM International Co., Ltd. ("NEXCOM"), a Taiwan-based pioneer in industrial computing and edge AI solutions.
accessnewswire.com
Collaboration Combines SmellTech and Edge AI for Intelligent Environmental Sensing Partnership Expands AI Nose's Industrial Ecosystem and Commercial Reach SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a leader in AI-powered scent digitization, today announced a strategic partnership with NEXCOM International Co., Ltd., a leader in industrial computing and edge AI solutions, to advance the integration of Ainos' AI Nose technology into NEXCOM's industrial edge computing platforms.
accessnewswire.com
New GICS code increases visibility among technology investors as Ainos builds commercial momentum around its AI-powered digital olfaction platform Expanded partnerships and IP portfolio to strengthen Ainos' SmellTech-as-a-Service model and competitive edge SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 7, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research (WTR) issued a new report spotlighting Ainos' formal reclassification under the Global Industry Classification Standard (GICS®) to the technology sector from biotechnology, effective October 1, 2025. The report recognizes Ainos' transformation into a technology-driven company built around its proprietary AI-powered digital olfaction platform, AI Nose.
accessnewswire.com
Five strategic industrial partnerships accelerate AI Nose adoption across semiconductors, robotics, smart manufacturing, and healthcare SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 2, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced its reclassification under the Global Industry Classification Standard (GICS®) to Technology Hardware, Storage & Peripherals (Code 45202030), effective October 1, 2025. The update, administered by S&P Dow Jones Indices and MSCI, marks Ainos' transition from biotechnology to the emerging field of digital olfaction-positioning the Company as a technology innovator enabling artificial intelligence to sense smell.
accessnewswire.com
New Patents in Europe, Germany, Taiwan, and China Strengthen SmellTech Leadership Expanding IP Moat to Accelerate Commercialization of AI Nose Across Healthcare, Semiconductors, and Robotics SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured seven new patents in Europe, Germany, Taiwan and China that strengthen its AI Nose digital olfaction platform and its applications in robotics. With these additions, Ainos now holds 123 active patents across key technologies, covering the U.S., Europe, Germany, Japan, Taiwan, and China.
accessnewswire.com
Fifth strategic industrial collaboration in 2025 strengthens Ainos' cross-industry ecosystem Topco partnership expands AI Nose's global reach across key industries, accelerating its path toward large-scale commercialization in 2026 SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 18, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has published a report spotlighting Ainos' distribution partnership with leading global semiconductor solutions provider Topco Scientific Co., Ltd. (TWSE: 5434, "Topco"), a milestone that propels the Company toward large-scale commercialization of its AI Nose platform in 2026.
accessnewswire.com
Partnership to accelerate commercialization of Ainos' AI Nose across semiconductors, healthcare, and smart manufacturing Topco brings 35 years of trusted global supply chain ties and customer access SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 16, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"), a pioneer in AI-powered scent digitization, today announced it has signed a distribution agreement with Topco Scientific Co., Ltd. (TWSE: 5434, "Topco"), one of Taiwan's leading semiconductor solution providers.
accessnewswire.com
AI Nose and Smell Language Model debut at SEMICON Taiwan 2025, bringing scent intelligence to the global semiconductor stage. Trainable, portable, cloud-connected AI Nose with SaaS model turns scent into insights for smart manufacturing SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 8, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it will showcase its AI Nose industrial module at SEMICON Taiwan 2025, held September 10-12 at the Taipei Nangang Exhibition Center.
accessnewswire.com
From biotech to SmellTech, Ainos transforms as a first mover in next-gen sensory AI Proprietary smell language model and scent data create unique competitive moat SmellTech flywheel spins toward 2026 scale-up, turning data into recurring revenue SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has published a report spotlighting AI Nose's first-mover breakthrough in giving AI the sense of smell, along with the Company's commercialization roadmap and pathway to profitability. The report draws insights from a management fireside chat on August 20, 2025.
accessnewswire.com
Early revenues and $2.1M SmellTech-as-a-Service order set the stage for large-scale commercialization in 2026 Robotics and industrial deployments expand long-term growth runway beyond healthcare SAN DIEGO, CA / ACCESS Newswire / August 19, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has assumed coverage of Ainos under its Technology research platform, transitioning from its prior coverage under the Emerging Growth category. This move underscores Ainos' strategic transformation from biotech roots to a multi-sector AI technology innovator, with its proprietary AI Nose platform poised to ignite the Company's next phase of growth across healthcare, robotics, and industrial applications.
See all news
